Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60) View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-11

AUTHORS

V. Tormo Ferrero, R. Duque Ugarte, M. Á. Berenguer Francés, R. Cardenal Maciá

ABSTRACT

INTRODUCTION: Endovaginal brachytherapy treatment dosimetry differences were studied using Ir-192 or Co-60 sources for postoperative endometrial cancer. MATERIALS AND METHODS: A prospective descriptive study was conducted. Thirty-six dosimetry plans of different patients were studied (15 by Ir-192 and 21 by Co-60). Variables studied included D2cc Rectum, D2cc Bladder, D2cc Sigmoid, dose percentage at point 0 (applicator surface on the top of the cylinder) and dose percentage at point 1 (5 mm deep on the top of the cylinder). A comparative analysis was performed of the values obtained from each variable between Ir-192 and Co-60 treatments. We compared average of each variables between Iridium and Cobalt by T Student for independent samples (SPSS 22). RESULTS: There were no significant differences on using Ir-192 or Co-60 by variables, except for dose percentage at point 1 in which we detected significant differences (Table 1). Table 1 The results Variables Sources Iridium 192 Cobalt 60 D2cc Rectum (mean dose) [rank] 6.01 Gy [3.99-7.90] 5.28 Gy [3.87-6,34] D2cc Bladder (mean dose) [rank] 5.82 Gy [4.20-8.38] 5.05 Gy [2.23-6.95] D2cc Sigmoid (mean dose) [rank] 4.43 Gy [1.66-6.67] 2.33 Gy [0.60-4.28] Dose percentage at point 0a (mean) [rank] 210.74% [120.90-234.90] 204.75% [177.10-223] Dose percentage at point 1b (mean) [rank] 93.49% [87.30-100.60] 100.11% [96.70-102] aPoint 0: point to the applicator surface bPoint 1: point to 5 mm applicator surface DISCUSSION: Brachytherapy treatment dosimetry plans are similar using Ir-192 or Co-60, except dose percentage at point 1. In the scientific literature, some differences exist and there are some advantages in using cobalt. More... »

PAGES

1409-1413

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x

DOI

http://dx.doi.org/10.1007/s12094-017-1670-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085422610

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28516398


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brachytherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cobalt Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endometrial Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iridium Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organs at Risk", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Planning, Computer-Assisted", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tormo Ferrero", 
        "givenName": "V.", 
        "id": "sg:person.012720576216.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012720576216.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Duque Ugarte", 
        "givenName": "R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berenguer Franc\u00e9s", 
        "givenName": "M. \u00c1.", 
        "id": "sg:person.07654670123.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07654670123.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cardenal Maci\u00e1", 
        "givenName": "R.", 
        "id": "sg:person.011566424025.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011566424025.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00066-008-1684-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012560788", 
          "https://doi.org/10.1007/s00066-008-1684-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5114/jcb.2011.26471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014593945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5114/jcb.2012.27952", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019091925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/bjr.20150010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064565562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/bjr.20150449", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064565726"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-11", 
    "datePublishedReg": "2017-11-01", 
    "description": "INTRODUCTION: Endovaginal brachytherapy treatment dosimetry differences were studied using Ir-192 or Co-60 sources for postoperative endometrial cancer.\nMATERIALS AND METHODS: A prospective descriptive study was conducted. Thirty-six dosimetry plans of different patients were studied (15 by Ir-192 and 21 by Co-60). Variables studied included D2cc Rectum, D2cc Bladder, D2cc Sigmoid, dose percentage at point 0 (applicator surface on the top of the cylinder) and dose percentage at point 1 (5\u00a0mm deep on the top of the cylinder). A comparative analysis was performed of the values obtained from each variable between Ir-192 and Co-60 treatments. We compared average of each variables between Iridium and Cobalt by T Student for independent samples (SPSS 22).\nRESULTS: There were no significant differences on using Ir-192 or Co-60 by variables, except for dose percentage at point 1 in which we detected significant differences (Table\u00a01). Table\u00a01 The results Variables Sources Iridium 192 Cobalt 60 D2cc Rectum (mean dose) [rank] 6.01\u00a0Gy [3.99-7.90] 5.28\u00a0Gy [3.87-6,34] D2cc Bladder (mean dose) [rank] 5.82\u00a0Gy [4.20-8.38] 5.05\u00a0Gy [2.23-6.95] D2cc Sigmoid (mean dose) [rank] 4.43\u00a0Gy [1.66-6.67] 2.33\u00a0Gy [0.60-4.28] Dose percentage at point 0a (mean) [rank] 210.74% [120.90-234.90] 204.75% [177.10-223] Dose percentage at point 1b (mean) [rank] 93.49% [87.30-100.60] 100.11% [96.70-102] aPoint 0: point to the applicator surface bPoint 1: point to 5\u00a0mm applicator surface DISCUSSION: Brachytherapy treatment dosimetry plans are similar using Ir-192 or Co-60, except dose percentage at point 1. In the scientific literature, some differences exist and there are some advantages in using cobalt.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12094-017-1670-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1035367", 
        "issn": [
          "1699-048X", 
          "1699-3055"
        ], 
        "name": "Clinical and Translational Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60)", 
    "pagination": "1409-1413", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4904f4e26f1f694871febf9b02cae1982dbb5f64c105d900eabf65fd817f0c53"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28516398"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101247119"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12094-017-1670-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085422610"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12094-017-1670-x", 
      "https://app.dimensions.ai/details/publication/pub.1085422610"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89785_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12094-017-1670-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'


 

This table displays all metadata directly associated to this object as RDF triples.

161 TRIPLES      21 PREDICATES      48 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12094-017-1670-x schema:about N117e94029945461d9f1669b1f63508df
2 N269fa2c6bd6949e6b10958e2e4bd3534
3 N360921866f4044bf90a58335b9b8cad0
4 N420acefeb91c482ca2165bc13e85e4ab
5 N60a69465dadd4ad0969f83099d39daca
6 N62545cf48ca743b6a81f0e8ef8fa3761
7 N7ad9ced484214108a257f4dade020081
8 N8d5519736c9e42a69f8e339fd2781fd9
9 Na1aa9fc9a3a745a4a380ad537f342da5
10 Na9cdfa7bcd5d4d92b7173f72144668d8
11 Nbf70ae2d43454c09acc3582d96f19840
12 Nd2254598605a4932bf24148a3dc69bfd
13 Ndb6e08e020af4b7d9a8cb74629f1defb
14 Nfeb4cfe3704b41df9f1d8a219303c65d
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Na17a5779e5c54ff397f34202b1a418d4
18 schema:citation sg:pub.10.1007/s00066-008-1684-y
19 https://doi.org/10.1259/bjr.20150010
20 https://doi.org/10.1259/bjr.20150449
21 https://doi.org/10.5114/jcb.2011.26471
22 https://doi.org/10.5114/jcb.2012.27952
23 schema:datePublished 2017-11
24 schema:datePublishedReg 2017-11-01
25 schema:description INTRODUCTION: Endovaginal brachytherapy treatment dosimetry differences were studied using Ir-192 or Co-60 sources for postoperative endometrial cancer. MATERIALS AND METHODS: A prospective descriptive study was conducted. Thirty-six dosimetry plans of different patients were studied (15 by Ir-192 and 21 by Co-60). Variables studied included D2cc Rectum, D2cc Bladder, D2cc Sigmoid, dose percentage at point 0 (applicator surface on the top of the cylinder) and dose percentage at point 1 (5 mm deep on the top of the cylinder). A comparative analysis was performed of the values obtained from each variable between Ir-192 and Co-60 treatments. We compared average of each variables between Iridium and Cobalt by T Student for independent samples (SPSS 22). RESULTS: There were no significant differences on using Ir-192 or Co-60 by variables, except for dose percentage at point 1 in which we detected significant differences (Table 1). Table 1 The results Variables Sources Iridium 192 Cobalt 60 D2cc Rectum (mean dose) [rank] 6.01 Gy [3.99-7.90] 5.28 Gy [3.87-6,34] D2cc Bladder (mean dose) [rank] 5.82 Gy [4.20-8.38] 5.05 Gy [2.23-6.95] D2cc Sigmoid (mean dose) [rank] 4.43 Gy [1.66-6.67] 2.33 Gy [0.60-4.28] Dose percentage at point 0a (mean) [rank] 210.74% [120.90-234.90] 204.75% [177.10-223] Dose percentage at point 1b (mean) [rank] 93.49% [87.30-100.60] 100.11% [96.70-102] aPoint 0: point to the applicator surface bPoint 1: point to 5 mm applicator surface DISCUSSION: Brachytherapy treatment dosimetry plans are similar using Ir-192 or Co-60, except dose percentage at point 1. In the scientific literature, some differences exist and there are some advantages in using cobalt.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N88454a3c881f4c3ba2f295f1cd88a6d1
30 Nffc17ffb2c9a4833866cd78f37b55c83
31 sg:journal.1035367
32 schema:name Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60)
33 schema:pagination 1409-1413
34 schema:productId N2d56224510f5494ebd73ca428a4c2e66
35 N522d47d7d565403bba9f7fe12f332402
36 N73b0a674a75b4189be6c497019f42c45
37 Nd1572d6904484f53af5380e4e38c1713
38 Nff91f93b845d4fe881536acd3aa95186
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085422610
40 https://doi.org/10.1007/s12094-017-1670-x
41 schema:sdDatePublished 2019-04-11T09:49
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher Ncd4a00bd9ef242cab01c1cbacdc50803
44 schema:url https://link.springer.com/10.1007%2Fs12094-017-1670-x
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N117e94029945461d9f1669b1f63508df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Radiotherapy Planning, Computer-Assisted
50 rdf:type schema:DefinedTerm
51 N262047b1708848528a0839c810dee8dd schema:affiliation https://www.grid.ac/institutes/grid.411263.3
52 schema:familyName Duque Ugarte
53 schema:givenName R.
54 rdf:type schema:Person
55 N269fa2c6bd6949e6b10958e2e4bd3534 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Iridium Radioisotopes
57 rdf:type schema:DefinedTerm
58 N2d56224510f5494ebd73ca428a4c2e66 schema:name dimensions_id
59 schema:value pub.1085422610
60 rdf:type schema:PropertyValue
61 N360921866f4044bf90a58335b9b8cad0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Prospective Studies
63 rdf:type schema:DefinedTerm
64 N420acefeb91c482ca2165bc13e85e4ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Radiotherapy Dosage
66 rdf:type schema:DefinedTerm
67 N522d47d7d565403bba9f7fe12f332402 schema:name readcube_id
68 schema:value 4904f4e26f1f694871febf9b02cae1982dbb5f64c105d900eabf65fd817f0c53
69 rdf:type schema:PropertyValue
70 N60a69465dadd4ad0969f83099d39daca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Female
72 rdf:type schema:DefinedTerm
73 N62545cf48ca743b6a81f0e8ef8fa3761 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Humans
75 rdf:type schema:DefinedTerm
76 N6a4d088962694cfbb8d3f7b440110195 rdf:first sg:person.011566424025.18
77 rdf:rest rdf:nil
78 N73b0a674a75b4189be6c497019f42c45 schema:name doi
79 schema:value 10.1007/s12094-017-1670-x
80 rdf:type schema:PropertyValue
81 N7ad9ced484214108a257f4dade020081 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Follow-Up Studies
83 rdf:type schema:DefinedTerm
84 N88454a3c881f4c3ba2f295f1cd88a6d1 schema:volumeNumber 19
85 rdf:type schema:PublicationVolume
86 N8d5519736c9e42a69f8e339fd2781fd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Cobalt Radioisotopes
88 rdf:type schema:DefinedTerm
89 Na17a5779e5c54ff397f34202b1a418d4 rdf:first sg:person.012720576216.16
90 rdf:rest Nc76e87e6a3c64cb4b70c90225971ca0c
91 Na1aa9fc9a3a745a4a380ad537f342da5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Organs at Risk
93 rdf:type schema:DefinedTerm
94 Na9cdfa7bcd5d4d92b7173f72144668d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Prognosis
96 rdf:type schema:DefinedTerm
97 Nbf70ae2d43454c09acc3582d96f19840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Radiometry
99 rdf:type schema:DefinedTerm
100 Nc5ce90d9513f4268a9489d8527a1a5ec rdf:first sg:person.07654670123.73
101 rdf:rest N6a4d088962694cfbb8d3f7b440110195
102 Nc76e87e6a3c64cb4b70c90225971ca0c rdf:first N262047b1708848528a0839c810dee8dd
103 rdf:rest Nc5ce90d9513f4268a9489d8527a1a5ec
104 Ncd4a00bd9ef242cab01c1cbacdc50803 schema:name Springer Nature - SN SciGraph project
105 rdf:type schema:Organization
106 Nd1572d6904484f53af5380e4e38c1713 schema:name pubmed_id
107 schema:value 28516398
108 rdf:type schema:PropertyValue
109 Nd2254598605a4932bf24148a3dc69bfd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Brachytherapy
111 rdf:type schema:DefinedTerm
112 Ndb6e08e020af4b7d9a8cb74629f1defb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Endometrial Neoplasms
114 rdf:type schema:DefinedTerm
115 Nfeb4cfe3704b41df9f1d8a219303c65d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Postoperative Care
117 rdf:type schema:DefinedTerm
118 Nff91f93b845d4fe881536acd3aa95186 schema:name nlm_unique_id
119 schema:value 101247119
120 rdf:type schema:PropertyValue
121 Nffc17ffb2c9a4833866cd78f37b55c83 schema:issueNumber 11
122 rdf:type schema:PublicationIssue
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
127 schema:name Clinical Sciences
128 rdf:type schema:DefinedTerm
129 sg:journal.1035367 schema:issn 1699-048X
130 1699-3055
131 schema:name Clinical and Translational Oncology
132 rdf:type schema:Periodical
133 sg:person.011566424025.18 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
134 schema:familyName Cardenal Maciá
135 schema:givenName R.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011566424025.18
137 rdf:type schema:Person
138 sg:person.012720576216.16 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
139 schema:familyName Tormo Ferrero
140 schema:givenName V.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012720576216.16
142 rdf:type schema:Person
143 sg:person.07654670123.73 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
144 schema:familyName Berenguer Francés
145 schema:givenName M. Á.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07654670123.73
147 rdf:type schema:Person
148 sg:pub.10.1007/s00066-008-1684-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1012560788
149 https://doi.org/10.1007/s00066-008-1684-y
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1259/bjr.20150010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064565562
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1259/bjr.20150449 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064565726
154 rdf:type schema:CreativeWork
155 https://doi.org/10.5114/jcb.2011.26471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014593945
156 rdf:type schema:CreativeWork
157 https://doi.org/10.5114/jcb.2012.27952 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019091925
158 rdf:type schema:CreativeWork
159 https://www.grid.ac/institutes/grid.411263.3 schema:alternateName Hospital Universitari Sant Joan D'Alacant
160 schema:name Radiotherapy Oncology Department, Hospital Universitari Sant Joan d´Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d´Alacant, 03550, Alicante, Spain
161 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...